AnGes Inc
AJW
Company Profile
Business description
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.
Contact
7-7-15, Saito-asagi
4F, Saito Bio-Incubator
Ibaraki
Osaka567-0085
JPNSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
154
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,394.60 | 28.20 | -0.33% |
CAC 40 | 7,371.71 | 37.40 | -0.50% |
DAX 40 | 19,147.85 | 107.12 | -0.56% |
Dow JONES (US) | 41,794.60 | 257.59 | -0.61% |
FTSE 100 | 8,184.24 | 7.09 | 0.09% |
HKSE | 20,823.36 | 255.84 | 1.24% |
NASDAQ | 18,179.98 | 59.93 | -0.33% |
Nikkei 225 | 38,567.63 | 513.96 | 1.35% |
NZX 50 Index | 12,658.30 | 67.70 | 0.54% |
S&P 500 | 5,712.69 | 16.11 | -0.28% |
S&P/ASX 200 | 8,137.70 | 26.90 | -0.33% |
SSE Composite Index | 3,369.70 | 59.49 | 1.80% |